LABORATORY CORP OF AMERICA HOLDINGS·4

May 5, 10:48 AM ET

BELINGARD JEAN-LUC 4

4 · LABORATORY CORP OF AMERICA HOLDINGS · Filed May 5, 2021

Insider Transaction Report

Form 4
Period: 2021-05-03
Transactions
  • Sale

    Common Stock

    2021-05-03$269.16/sh2,600$699,80315,569 total
  • Exercise/Conversion

    Common Stock

    2021-05-03$98.49/sh+2,600$256,07418,169 total
  • Exercise/Conversion

    Non-qualified Stock Options

    2021-05-032,6000 total
    Exercise: $98.49From: 2012-05-11Exp: 2021-05-11Common Stock (2,600 underlying)
Footnotes (3)
  • [F1]The price of $269.1551 per share represents a weighted average of sales prices ranging from $269.06 to $269.291 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  • [F2]Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
  • [F3]The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT